Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Villa

Showing results (71-80 of 87) with videos related to

Pageof 9
Sort By:
The Lancet. Infectious Diseases|June 9, 2023
A partner protection package for HIV cure-related trials involving analytical treatment interruptionsKarine Dubé, Tia Morton, Lawrence Fox, et al.
Journal of the International AIDS Society|July 4, 2025
"A cure might help, but it won't erase it all": a qualitative study of policy challenges and priorities for long-term survivors of HIV in the United StatesAli Ahmed, Jeff Taylor, Rachel Lau, et al.
Transplant Infectious Disease : an Official Journal of the Transplantation Society|July 5, 2016
Progressive increase of resistance in Enterobacteriaceae urinary isolates from kidney transplant recipients over the past decade: narrowing of the therapeutic optionsJ Origüen, M Fernández-Ruiz, F López-Medrano, et al.
Genetic Counseling (Geneva, Switzerland)|October 23, 2010
A familial reciprocal translocation t(1;15) in three generations identified in a regular trisomy 21 patientC García-Delgado, E Bahena-Martínez, A Aparicio-Onofre, et al.
Neurologia (Barcelona, Spain)|December 18, 2010
[Intracranial gangliogliomas. A review of a series of 20 patients]M Gelabert-González, J M Santín Amo, A Arcos Algaba, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|August 17, 2017
Comparison of the clinical course of Clostridium difficile infection in glutamate dehydrogenase-positive toxin-negative patients diagnosed by PCR to those with a positive toxin testJ Origüen, L Corbella, M Á Orellana, et al.
Cancer Radiotherapie : Journal De La Societe Francaise De Radiotherapie Oncologique|March 9, 2022
Final results of the IFCT-0803 study, a phase II study of cetuximab, pemetrexed, cisplatin, and concurrent radiotherapy in patients with locally advanced, unresectable, stage III, non-squamous, non-small-cell lung cancerJ Trédaniel, F Barlési, C Le Péchoux, et al.
AIDS (London, England)|October 20, 2023
People with HIV at the end-of-life and their next-of-kin/loved ones are willing to participate in interventional HIV cure-related researchSamuel O Ndukwe, Hursch Patel, Brittany Shelton, et al.
Journal of Virus Eradication|July 13, 2023
Perceived risks and benefits of enrolling people with HIV at the end of life in cure research in Southern California, United StatesKarine Dubé, Brittany Shelton, Hursch Patel, et al.
International Journal of Environmental Research and Public Health|March 28, 2026
Intersectionality-Informed HIV Cure-Related Research at the End of Life: A Call to ActionAli Ahmed, Brittany Shelton, Malachi P Keo, et al.
Pageof 9

Showing results (71-80 of 87) with videos related to

Sort By:
Pageof 9
The Lancet. Infectious Diseases|June 9, 2023
A partner protection package for HIV cure-related trials involving analytical treatment interruptionsKarine Dubé, Tia Morton, Lawrence Fox, et al.
Journal of the International AIDS Society|July 4, 2025
"A cure might help, but it won't erase it all": a qualitative study of policy challenges and priorities for long-term survivors of HIV in the United StatesAli Ahmed, Jeff Taylor, Rachel Lau, et al.
Transplant Infectious Disease : an Official Journal of the Transplantation Society|July 5, 2016
Progressive increase of resistance in Enterobacteriaceae urinary isolates from kidney transplant recipients over the past decade: narrowing of the therapeutic optionsJ Origüen, M Fernández-Ruiz, F López-Medrano, et al.
Genetic Counseling (Geneva, Switzerland)|October 23, 2010
A familial reciprocal translocation t(1;15) in three generations identified in a regular trisomy 21 patientC García-Delgado, E Bahena-Martínez, A Aparicio-Onofre, et al.
Neurologia (Barcelona, Spain)|December 18, 2010
[Intracranial gangliogliomas. A review of a series of 20 patients]M Gelabert-González, J M Santín Amo, A Arcos Algaba, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|August 17, 2017
Comparison of the clinical course of Clostridium difficile infection in glutamate dehydrogenase-positive toxin-negative patients diagnosed by PCR to those with a positive toxin testJ Origüen, L Corbella, M Á Orellana, et al.
Cancer Radiotherapie : Journal De La Societe Francaise De Radiotherapie Oncologique|March 9, 2022
Final results of the IFCT-0803 study, a phase II study of cetuximab, pemetrexed, cisplatin, and concurrent radiotherapy in patients with locally advanced, unresectable, stage III, non-squamous, non-small-cell lung cancerJ Trédaniel, F Barlési, C Le Péchoux, et al.
AIDS (London, England)|October 20, 2023
People with HIV at the end-of-life and their next-of-kin/loved ones are willing to participate in interventional HIV cure-related researchSamuel O Ndukwe, Hursch Patel, Brittany Shelton, et al.
Journal of Virus Eradication|July 13, 2023
Perceived risks and benefits of enrolling people with HIV at the end of life in cure research in Southern California, United StatesKarine Dubé, Brittany Shelton, Hursch Patel, et al.
International Journal of Environmental Research and Public Health|March 28, 2026
Intersectionality-Informed HIV Cure-Related Research at the End of Life: A Call to ActionAli Ahmed, Brittany Shelton, Malachi P Keo, et al.
Pageof 9